✦ LIBER ✦

A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer

✍ Scribed by Stuart P. Leitner; George J. Bosl; Elliot W. Strong; Frank P. Gerold; Ronald H. Spiro; Jatin P. Shah; Roy B. Sessions; Bhadrasain Vikram

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 432 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860901)58:5<1014::aid-cncr2820580504>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced cancer of the head

Treatment of advanced cancer of the head and neck

✍ Fred J. Ansfield; Guillermo Ramirez; Hugh L. Davis Jr.; Bernard C. Korbitz; Halv 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

High-dose cisplatin for locally advanced

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

✍ Kathleen A. Havlin; John G. Kuhn; J. William Myers; Robert F. Ozols; Douglas E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 1 views

Simultaneous radiochemotherapy in the tr

Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers. A single-institution study

✍ Giovanni Franchin; Carlo Gobitti; Emilio Minatel; Antonino de Paoli; Gianni Boz; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Background. Patients with advanced, inoperable head and neck cancers have cure rates of approximately 10-15%. In these patients, concomitant chemoradiotherapy seems to improve local control and survival. 5-Fluorouracil(5-FU) administered by continuous infusion and cisplatin plus concomitant conventi

Clinical evaluation of the treatment of

Clinical evaluation of the treatment of advanced head and neck cancers with high-energy electron beams

✍ Harold Perry; Florence C. H. Chu; Toshio Kitagawa; Arvin S. Glicksman; James J. 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB 👁 2 views

Vinorelbine, cisplatin, and 5-fluorourac

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck : Results of a Phase II multicenter study

✍ Vittorio Gebbia; Glovanni Mantovani; Antonio Farris; Biagio Agostara; Alberto De 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## BACKGROUND. The combination of vinorelbine (VNR), cisplatin (CDDP), and 5-fluoro-

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the